The AngelMed Guardian System is a single-lead, implantable cardiac device designed to detect acute ischemic events and to prompt the patient to seek medical attention for a potential acute coronary syndrome (ACS) event. The FDA approved this device in April 2018 for use an adjunct to patient-recognized symptoms predictive of ACS in patients who have had prior acute ACS events and who remain at high risk for recurrent ACS events.


If you have a Hayes login, click here to view the full report on the Knowledge Center.